PD-1 expressed in T cells or antigen-presenting cells (APCs) interacts with the PD-L1 expressed in tumor cells, resulting in the inhibition of intracellular signaling and effector T cell activation; thus, PD-1 functions as a checkpoint in the immune process [7]. This evidence concerns the gene CD274 and neoplasm.